ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,746Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 93

$435K Total Retail Price of All Prescriptions

Rank: 12 out of 93

257 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 257 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

16% of this provider’s 257 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 552 527 1 4
LISINOPRIL 474 442 2 3
WARFARIN SODIUM 367 360 3 12
LEVOTHYROXINE SODIUM 357 291 4 5
SIMVASTATIN 326 279 5 2
POTASSIUM CHLORIDE 297 281 6 13
METOPROLOL SUCCINATE 281 245 7 14
LOVASTATIN 261 219 8 38
METOPROLOL TARTRATE 245 178 9 11
OMEPRAZOLE 229 177 10 8
AMLODIPINE BESYLATE 222 188 11 6
TRAMADOL HCL 206 180 12 15
CARVEDILOL 185 185 13 23
ATENOLOL 169 154 14 16
HYDROCODONE-ACETAMINOPHEN 160 141 S3 15 9
PRAVASTATIN SODIUM 155 139 16 20
METFORMIN HCL 143 103 17 7
CLOPIDOGREL 134 115 18 27
DONEPEZIL HCL 128 127 19 25
ALLOPURINOL 122 110 20 29
RANITIDINE HCL 119 84 21 21
ATORVASTATIN CALCIUM 112 77 22 18
GLYBURIDE 106 96 R 23 47
DIGOXIN 100 96 24 48
KLOR-CON M20 98 87 25 86
NEXIUM 98 48 25 33
LOSARTAN POTASSIUM 97 97 27 26
PLAVIX 96 82 28 44
CIPROFLOXACIN HCL 93 78 29 106
CITALOPRAM HBR 92 64 30 45
SERTRALINE HCL 82 62 31 43
NAMENDA 78 77 32 55
PANTOPRAZOLE SODIUM 78 78 32 36
AMITRIPTYLINE HCL 74 62 R 34 61
CEPHALEXIN 74 58 34 80
ROPINIROLE HCL 72 72 36 120
HYDROCHLOROTHIAZIDE 71 61 37 10
KLOR-CON 8 70 70 38 101
ZETIA 69 68 39 92
TRAZODONE HCL 68 52 40 85
FENTANYL 63 62 S2 41 87
MELOXICAM 62 52 42 42
OXYBUTYNIN CHLORIDE ER 61 45 43 78
PROPRANOLOL HCL 61 39 43 93
ACETAMINOPHEN-CODEINE 58 53 S3 45 65
BENAZEPRIL HCL 57 44 46 79
CRESTOR 56 26 47 31
FELODIPINE ER 56 56 47 107
LEVOFLOXACIN 55 47 49 103
QUETIAPINE FUMARATE 53 44 50 104
CEFUROXIME 50 48 51 245
ALENDRONATE SODIUM 50 40 51 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.